Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4

Obesity is a risk factor for breast cancer and also predicts poor clinical outcomes regardless of menopausal status. Contributing to the poor clinical outcomes is the suboptimal efficacy of standard therapies due to dose limiting toxicities and obesity-related complications, highlighting the need to...

Full description

Bibliographic Details
Main Authors: Kolb, Ryan, Kluz, Paige, Tan, Zhen Wei, Borcherding, Nicholas, Bormann, Nicholas, Vishwakarma, Ajaykumar, Balcziak, Louis, Zhu, Pengcheng, Davies, Brandon S. J., Gourronc, Francoise, Liu, Ling-Zhi, Ge, Xin, Jiang, Bing-Hua, Gibson-Corley, Katherine, Klingelhutz, Aloysius, Tan, Nguan Soon, Zhu, Yuwen, Sutterwala, Fayyaz S., Shen, Xian, Zhang, Weizhou
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2021
Subjects:
Online Access:https://hdl.handle.net/10356/146661
_version_ 1811678276673863680
author Kolb, Ryan
Kluz, Paige
Tan, Zhen Wei
Borcherding, Nicholas
Bormann, Nicholas
Vishwakarma, Ajaykumar
Balcziak, Louis
Zhu, Pengcheng
Davies, Brandon S. J.
Gourronc, Francoise
Liu, Ling-Zhi
Ge, Xin
Jiang, Bing-Hua
Gibson-Corley, Katherine
Klingelhutz, Aloysius
Tan, Nguan Soon
Zhu, Yuwen
Sutterwala, Fayyaz S.
Shen, Xian
Zhang, Weizhou
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Kolb, Ryan
Kluz, Paige
Tan, Zhen Wei
Borcherding, Nicholas
Bormann, Nicholas
Vishwakarma, Ajaykumar
Balcziak, Louis
Zhu, Pengcheng
Davies, Brandon S. J.
Gourronc, Francoise
Liu, Ling-Zhi
Ge, Xin
Jiang, Bing-Hua
Gibson-Corley, Katherine
Klingelhutz, Aloysius
Tan, Nguan Soon
Zhu, Yuwen
Sutterwala, Fayyaz S.
Shen, Xian
Zhang, Weizhou
author_sort Kolb, Ryan
collection NTU
description Obesity is a risk factor for breast cancer and also predicts poor clinical outcomes regardless of menopausal status. Contributing to the poor clinical outcomes is the suboptimal efficacy of standard therapies due to dose limiting toxicities and obesity-related complications, highlighting the need to develop novel therapeutic approaches for treating obese patients. We recently found that obesity leads to an increase in tumor-infiltrating macrophages with activated NLRC4 inflammasome and increased interleukin (IL)−1β production. IL-1β, in turn, leads to increased angiogenesis and cancer progression. Using Next Generation RNA sequencing, we identified an NLRC4/IL-1β-dependent upregulation of angiopoietin-like 4 (ANGPTL4), a known angiogenic factor in cancer, in tumors from obese mice. ANGPTL4-deficiency by genetic knockout or treatment with a neutralizing antibody led to a significant reduction in obesity-induced angiogenesis and tumor growth. At a mechanistic level, ANGPTL4 expression is induced by IL-1β from primary adipocytes in a manner dependent on NF-κB- and MAP kinase-activation, which is further enhanced by hypoxia. This report shows that adipocyte-derived ANGPTL4 drives disease progression under obese conditions and is a potential therapeutic target for treating obese breast cancer patients.
first_indexed 2024-10-01T02:50:42Z
format Journal Article
id ntu-10356/146661
institution Nanyang Technological University
language English
last_indexed 2024-10-01T02:50:42Z
publishDate 2021
record_format dspace
spelling ntu-10356/1466612023-02-28T17:08:29Z Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4 Kolb, Ryan Kluz, Paige Tan, Zhen Wei Borcherding, Nicholas Bormann, Nicholas Vishwakarma, Ajaykumar Balcziak, Louis Zhu, Pengcheng Davies, Brandon S. J. Gourronc, Francoise Liu, Ling-Zhi Ge, Xin Jiang, Bing-Hua Gibson-Corley, Katherine Klingelhutz, Aloysius Tan, Nguan Soon Zhu, Yuwen Sutterwala, Fayyaz S. Shen, Xian Zhang, Weizhou Lee Kong Chian School of Medicine (LKCMedicine) School of Biological Sciences Science::Medicine Breast Cancer Inflammation Obesity is a risk factor for breast cancer and also predicts poor clinical outcomes regardless of menopausal status. Contributing to the poor clinical outcomes is the suboptimal efficacy of standard therapies due to dose limiting toxicities and obesity-related complications, highlighting the need to develop novel therapeutic approaches for treating obese patients. We recently found that obesity leads to an increase in tumor-infiltrating macrophages with activated NLRC4 inflammasome and increased interleukin (IL)−1β production. IL-1β, in turn, leads to increased angiogenesis and cancer progression. Using Next Generation RNA sequencing, we identified an NLRC4/IL-1β-dependent upregulation of angiopoietin-like 4 (ANGPTL4), a known angiogenic factor in cancer, in tumors from obese mice. ANGPTL4-deficiency by genetic knockout or treatment with a neutralizing antibody led to a significant reduction in obesity-induced angiogenesis and tumor growth. At a mechanistic level, ANGPTL4 expression is induced by IL-1β from primary adipocytes in a manner dependent on NF-κB- and MAP kinase-activation, which is further enhanced by hypoxia. This report shows that adipocyte-derived ANGPTL4 drives disease progression under obese conditions and is a potential therapeutic target for treating obese breast cancer patients. Ministry of Education (MOE) Accepted version RK: NIH T32 AI007260; WZ: NIH R01 grants CA200673 and CA203834, Oberley Award (National Cancer Institute Award P30CA086862) from Holden Comprehensive Cancer Center at the University of Iowa; NB: NIH F30 CA206255; AK: Mark Stinski Developmental Grant from the Department of Microbiology, University of Iowa; BD: NIH R01HL130146; NST: grant from Ministry of Education, Singapore (MOE2014-T2-1-012); FSS: NIH R01AI118719. 2021-03-04T06:36:15Z 2021-03-04T06:36:15Z 2018 Journal Article Kolb, R., Kluz, P., Tan, Z. W., Borcherding, N., Bormann, N., Vishwakarma, A., . . . Zhang, W. (2019). Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene, 38(13), 2351-2363. doi:10.1038/s41388-018-0592-6 0950-9232 https://hdl.handle.net/10356/146661 10.1038/s41388-018-0592-6 30518876 13 38 2351 2363 en MOE2014-T2-1-012 Oncogene © 2018 Springer Nature Limited. All rights reserved. This paper was published in Oncogene and is made available with permission of Springer Nature Limited. application/pdf
spellingShingle Science::Medicine
Breast Cancer
Inflammation
Kolb, Ryan
Kluz, Paige
Tan, Zhen Wei
Borcherding, Nicholas
Bormann, Nicholas
Vishwakarma, Ajaykumar
Balcziak, Louis
Zhu, Pengcheng
Davies, Brandon S. J.
Gourronc, Francoise
Liu, Ling-Zhi
Ge, Xin
Jiang, Bing-Hua
Gibson-Corley, Katherine
Klingelhutz, Aloysius
Tan, Nguan Soon
Zhu, Yuwen
Sutterwala, Fayyaz S.
Shen, Xian
Zhang, Weizhou
Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
title Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
title_full Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
title_fullStr Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
title_full_unstemmed Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
title_short Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
title_sort obesity associated inflammation promotes angiogenesis and breast cancer via angiopoietin like 4
topic Science::Medicine
Breast Cancer
Inflammation
url https://hdl.handle.net/10356/146661
work_keys_str_mv AT kolbryan obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT kluzpaige obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT tanzhenwei obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT borcherdingnicholas obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT bormannnicholas obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT vishwakarmaajaykumar obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT balcziaklouis obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT zhupengcheng obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT daviesbrandonsj obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT gourroncfrancoise obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT liulingzhi obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT gexin obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT jiangbinghua obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT gibsoncorleykatherine obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT klingelhutzaloysius obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT tannguansoon obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT zhuyuwen obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT sutterwalafayyazs obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT shenxian obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4
AT zhangweizhou obesityassociatedinflammationpromotesangiogenesisandbreastcancerviaangiopoietinlike4